Literature DB >> 8388679

Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications.

S Suga1, T Yoshikawa, Y Asano, T Kozawa, T Nakashima, I Kobayashi, T Yazaki, H Yamamoto, Y Kajita, T Ozaki.   

Abstract

Twenty-one infants who had virologically confirmed exanthem subitum and central nervous system (CNS) complications were studied to elucidate the clinical features, laboratory and virological findings, and outcome. The primary infection with human herpesvirus 6 was confirmed by isolation of the virus from blood, a significant rise in the antibody titers to the virus, or both. All convulsive seizures (15 generalized and 6 focal) occurred during the pre-eruptive stage of exanthem subitum. Four infants with encephalitis/encephalopathy had more severe clinical features with abnormalities demonstrated on electroencephalograms and cerebral computed tomograms. All infants except those with encephalitis/encephalopathy recovered without any sequelae. One infant with encephalitis/encephalopathy developed epilepsy and another one died. Human herpesvirus 6 DNA amplified by the nested polymerase chain reaction method was detected in the cerebrospinal fluid of 6 infants, including 3 with encephalitis/encephalopathy, of 11 patients examined by the fifth day of the illness. These findings suggest that CNS complications including encephalitis/encephalopathy occur at the pre-eruptive stage of exanthem subitum, that human herpesvirus 6 invades the CNS in some patients, and that the outcome is not always benign.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388679     DOI: 10.1002/ana.410330607

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Childhood Status Epilepticus.

Authors:  Jane G. Boggs; Elizabeth J. Waterhouse
Journal:  Epilepsy Curr       Date:  2001-09       Impact factor: 7.500

3.  Clinical characteristics of febrile convulsions during primary HHV-6 infection.

Authors:  S Suga; K Suzuki; M Ihira; T Yoshikawa; Y Kajita; T Ozaki; K Iida; Y Saito; Y Asano
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

4.  Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.

Authors:  Katherine N Ward; Hoe Nam Leong; Anton D Thiruchelvam; Claire E Atkinson; Duncan A Clark
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

5.  A study of childhood febrile convulsions with particular reference to HHV-6 infection: pathogenic considerations.

Authors:  M F Bertolani; M Portolani; F Marotti; A M Sabbattini; C Chiossi; M R Bandieri; G B Cavazzuti
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

Review 6.  Human herpesvirus-6 infections.

Authors:  C A Jones; D Isaacs
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

7.  Invasion by human herpesvirus 6 and human herpesvirus 7 of the central nervous system in patients with neurological signs and symptoms.

Authors:  T Yoshikawa; M Ihira; K Suzuki; S Suga; T Matsubara; S Furukawa; Y Asano
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

Review 8.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

9.  Basal ganglia infarction associated with HHV-6 infection.

Authors:  D W Webb; B H Bjornson; M A Sargent; J Hukin; E E Thomas
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

Review 10.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.